Bioactive Compounds, drawing inspiration from the remarkable designs found in nature, have emerged as a burgeoning field with applications ranging from medicine to engineering. Mimicking the structural and functional characteristics of biological systems, these materials offer unique properties such as strength, flexibility, self-healing, and biocompatibility. One prominent example is biomimetic materials designed to replicate the hierarchical structure of natural tissues like bone, cartilage, and skin. By incorporating features such as nanostructured scaffolds and mineralized matrices, these materials hold promise for tissue engineering and regenerative medicine applications, enabling the repair and replacement of damaged or diseased tissues. Additionally, Bioactive Compounds have been instrumental in developing advanced drug delivery systems that can mimic the behaviour of biological cells or organisms. For instance, liposomes and polymeric nanoparticles can be engineered to encapsulate drugs and release them in a controlled manner, mimicking the targeted delivery mechanisms found in biological systems. Furthermore, Bioactive Compounds have revolutionized the field of robotics and soft robotics, where flexible and adaptive materials inspired by muscles, tendons, and other biological structures enable the creation of robots with unprecedented capabilities. These biomimetic robots can navigate complex environments, interact safely with humans, and perform delicate tasks with precision. In the realm of architecture and construction, Bioactive Compounds offer innovative solutions for sustainability and resilience. Materials inspired by the structure of seashells, for example, can enhance the strength and durability of buildings while reducing material waste. Similarly, self-healing materials inspired by the regenerative abilities of living organisms have the potential to extend the lifespan of infrastructure and minimize maintenance costs. Despite their vast potential, the development of Bioactive Compounds also poses challenges related to scalability, reproducibility, and environmental impact.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States